162 related articles for article (PubMed ID: 16708907)
1. [The carcinoembryonic antigen: apropos of an old friend].
Téllez-Avila FI; García-Osogobio SM
Rev Invest Clin; 2005; 57(6):814-9. PubMed ID: 16708907
[TBL] [Abstract][Full Text] [Related]
2. Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy.
Clarke P; Mann J; Simpson JF; Rickard-Dickson K; Primus FJ
Cancer Res; 1998 Apr; 58(7):1469-77. PubMed ID: 9537250
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen: cell adhesion molecule and useful diagnostic marker.
Maxwell P
Br J Biomed Sci; 1999; 56(3):209-14. PubMed ID: 10824332
[TBL] [Abstract][Full Text] [Related]
4. Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccine.
Conry RM; Allen KO; Lee S; Moore SE; Shaw DR; LoBuglio AF
Clin Cancer Res; 2000 Jan; 6(1):34-41. PubMed ID: 10656429
[TBL] [Abstract][Full Text] [Related]
5. Specificity of anti-carcinoembryonic antigen monoclonal antibodies and their effects on CEA-mediated adhesion.
Zhou H; Stanners CP; Fuks A
Cancer Res; 1993 Aug; 53(16):3817-22. PubMed ID: 7687926
[TBL] [Abstract][Full Text] [Related]
6. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
7. Mice transgenic for the human carcinoembryonic antigen gene maintain its spatiotemporal expression pattern.
Eades-Perner AM; van der Putten H; Hirth A; Thompson J; Neumaier M; von Kleist S; Zimmermann W
Cancer Res; 1994 Aug; 54(15):4169-76. PubMed ID: 8033149
[TBL] [Abstract][Full Text] [Related]
8. CEA-based vaccines.
Huang EH; Kaufman HL
Expert Rev Vaccines; 2002 Jun; 1(1):49-63. PubMed ID: 12908512
[TBL] [Abstract][Full Text] [Related]
9. [CEACAM1--a less well-known member of the family of carcinoembryonic antigens].
Muchová L; Vítek L; Jirsa M
Cas Lek Cesk; 2003; 142(5):259-63. PubMed ID: 12920788
[TBL] [Abstract][Full Text] [Related]
10. Expression of carcinoembryonic antigen and nonspecific cross-reacting 50-kDa antigen in human normal and cancerous colon mucosa: comparative ultrastructural study with monoclonal antibodies.
Baranov V; Yeung MM; Hammarström S
Cancer Res; 1994 Jun; 54(12):3305-14. PubMed ID: 8205554
[TBL] [Abstract][Full Text] [Related]
11. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues.
Hammarström S
Semin Cancer Biol; 1999 Apr; 9(2):67-81. PubMed ID: 10202129
[TBL] [Abstract][Full Text] [Related]
12. A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses.
Conforti A; Peruzzi D; Giannetti P; Biondo A; Ciliberto G; La Monica N; Aurisicchio L
J Immunother; 2009 Sep; 32(7):744-54. PubMed ID: 19561534
[TBL] [Abstract][Full Text] [Related]
13. Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors.
Wilkinson RW; Ross EL; Poulsom R; Ilyas M; Straub J; Snary D; Bodmer WF; Mather SJ
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10256-60. PubMed ID: 11517330
[TBL] [Abstract][Full Text] [Related]
14. Balancing between antitumor efficacy and autoimmune pathology in T-cell-mediated targeting of carcinoembryonic antigen.
Bos R; van Duikeren S; Morreau H; Franken K; Schumacher TN; Haanen JB; van der Burg SH; Melief CJ; Offringa R
Cancer Res; 2008 Oct; 68(20):8446-55. PubMed ID: 18922918
[TBL] [Abstract][Full Text] [Related]
15. Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.
Zbar AP; Lemoine NR; Wadhwa M; Thomas H; Snary D; Kmiot WA
Br J Cancer; 1998 Mar; 77(5):683-93. PubMed ID: 9514045
[No Abstract] [Full Text] [Related]
16. Chromosomal localization of the carcinoembryonic antigen gene family and differential expression in various tumors.
Zimmermann W; Weber B; Ortlieb B; Rudert F; Schempp W; Fiebig HH; Shively JE; von Kleist S; Thompson JA
Cancer Res; 1988 May; 48(9):2550-4. PubMed ID: 3356015
[TBL] [Abstract][Full Text] [Related]
17. Co-administration of carcinoembryonic antigen and HIV TAT fusion protein with CpG-oligodeoxynucleotide induces potent antitumor immunity.
Woo SJ; Kim CH; Park MY; Kim HS; Sohn HJ; Park JS; Kim HJ; Oh ST; Kim TG
Cancer Sci; 2008 May; 99(5):1034-9. PubMed ID: 18294279
[TBL] [Abstract][Full Text] [Related]
18. Clinical applications of carcinoembryonic antigen.
Sikorska H; Shuster J; Gold P
Cancer Detect Prev; 1988; 12(1-6):321-55. PubMed ID: 3052834
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen as an adhesion molecule.
Krop-Watorek A; Lisowska E
Arch Immunol Ther Exp (Warsz); 1998; 46(3):129-36. PubMed ID: 9704144
[TBL] [Abstract][Full Text] [Related]
20. Extracellular N-domain alone can mediate specific heterophilic adhesion between members of the carcinoembryonic antigen family, CEACAM6 and CEACAM8.
Oikawa S; Sugiyama M; Kuroki M; Kuroki M; Nakazato H
Biochem Biophys Res Commun; 2000 Nov; 278(3):564-8. PubMed ID: 11095950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
